BRAIN Initiative: Preclinical Proof of Concept for Novel Recording and Modulation Technologies in the Human CNS (R18)
Offered by Amyotrophic Lateral Sclerosis Assn · Arlington, VA
About this opportunity
This funding opportunity seeks applications for the translation of novel recording and modulation technologies in the human central nervous system, from device proof of concept up to the stage of readiness for first-in-human studies. The scope includes technology development, optimization, and pre-clinical testing for next-generation human CNS recording and/or modulation devices. Devices may be non-invasive, minimally invasive, implantable, or a combination thereof.
How to apply
Applications are handled on the funder's own website. Review the full guidelines and apply here: als.org/research/researchers/research-funding-opportunities. Confirm the deadline and eligibility directly with Amyotrophic Lateral Sclerosis Assn before applying.
See Amyotrophic Lateral Sclerosis Assn's full giving profile — its grant history, top recipients, and other funding priorities.
Is this grant a fit for your nonprofit?
Before you spend hours on an application, know whether it's worth it. Bespoke Grants scores any open RFP against your mission, budget, and service area — and finds the other funders you're missing. Free, no credit card.
Check my fit & find more grants →Other open opportunities from Amyotrophic Lateral Sclerosis Assn
Amyotrophic Lateral Sclerosis Assn currently lists 6 open opportunities in our index.
- BRAIN Initiative: Preclinical Proof of Concept for Novel Recording and Modulation Technologies in the Human CNS (R18 - Clinical Trial Not Allowed)
- Clinical Repurposing Research to Impact Veterans/Military
- Identify and Evaluate Potential Risk Factors for ALS
- Drs. Ayeez and Shelena Lalji & Family Student Scholar Award for Repair and Regenerative Mechanisms in ALS
- Clinical Trials to Validate AI-Driven Drug Repurposing
Frequently asked questions
- What is the deadline for BRAIN Initiative: Preclinical Proof of Concept for Novel Recording and Modulation Technologies in the Human CNS (R18)?
- The application deadline is May 28, 2026. Deadlines can change — always confirm directly with Amyotrophic Lateral Sclerosis Assn before applying.
- How much funding is available?
- The award range is Up to $750K.
- Where do I apply?
- Applications are submitted through Amyotrophic Lateral Sclerosis Assn's own website or process — see the "How to apply" section above.